Cancer Cell Membrane-Biomimetic Nanobubbles Carrying Indocyanine Green for Ultrasound/Fluorescence Bimodal Imaging of Colorectal Cancer
- 17 October 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Applied Nano Materials
- Vol. 9 (43) , 20376-20386
Abstract
The aim of this study was to construct cancer cell membrane-coated and Indocyanine green-loaded nanobubbles for targeted ultrasound/fluorescence bimodal imaging of colorectal cancer (CRC). ICG-loaded nanobubbles (ICG-NBs) and CT26 (a murine CRC cell line) cancer cell membrane-camouflaged and ICG-NBs (ICG-MNBs) were synthesized via mechanical oscillation. Physicochemical characterization included particle size and zeta potential, and in vitro ultrasound and fluorescence imaging were performed. The binding specificity of ICG-MNBs and ICG-NBs to CT26 cells was evaluated using confocal laser scanning microscopy (CLSM) and flow cytometry. Comparative bimodal imaging (ultrasound and fluorescence) of ICG-MNBs and ICG-NBs was performed in subcutaneous xenograft tumor models. Under a light and transmission electron microscope, ICG-MNBs were uniformly distributed and similar in size and shape. The addition of the cancer cell membrane reduced the particle size (p = 0.039) and decreased the zeta potential (p < 0.001). Both SDS-PAGE and CLSM results confirmed the successful hybridization of lipid and cell membranes (CM). CLSM and flow cytometry confirmed significantly enhanced binding specificity of ICG-MNBs to CT26 cells compared to that of ICG-NBs. In vitro ICG-MNBs and ICG-NBs imaging demonstrated concentration-dependent enhancements in ultrasound and fluorescence signal intensity. For in vivo imaging, compared with ICG-NBs, the signal intensity of tumors injected with ICG-MNBs was higher. Both results indicated that the modification of cancer CM can significantly enhance the targeted accumulation of nanobubbles to the corresponding tumor and improve the display ability of contrast-enhanced ultrasound and fluorescence imaging for the corresponding tumors. A safety study showed the certain biosafety of ICG-MNBs and that they could be used as a relatively safe ultrasound/fluorescence imaging contrast agent. This study demonstrates that ICG-MNBs represent a promising bimodal contrast agent for the precise diagnosis of CRC.Keywords
Funding Information
- Hospital Clinical Innovative Technology Cultivation Project (2026CXJS09)
- Hospital Clinical Innovative Technology Cultivation Project (2026JSYB09)
- National Natural Science Foundation of China (NSFC) (82502389)
This publication has 27 references indexed in Scilit:
- Intravitreal injection of cell membrane-coated nanoparticles for retinoblastoma treatmentJournal of Controlled Release, 2025
- Nanomaterials in the diagnosis and treatment of gastrointestinal tumors: New clinical choices and treatment strategiesMaterials Today Bio, 2025
- Cell membrane-camouflaged nanocarriers: A cutting-edge biomimetic technology to develop cancer immunotherapyInternational Journal of Pharmaceutics, 2025
- ESR Essentials: Imaging in colorectal cancer—practice recommendations by ESGAREuropean Radiology, 2024
- Cancer Cell Membrane‐Based Materials for Biomedical ApplicationsSmall, 2023
- Cancer Cell Membrane Nanodiscs for Antitumor VaccinationNano Letters, 2023
- Current understanding of passive and active targeting nanomedicines to enhance tumor accumulationCoordination Chemistry Reviews, 2023
- Sponge-like nano-system suppresses tumor recurrence and metastasis by restraining myeloid-derived suppressor cells-mediated immunosuppression and formation of pre-metastatic nicheActa Biomaterialia, 2023
- Cell membrane coated-nanoparticles for cancer immunotherapyActa Pharmaceutica Sinica B, 2022
- Ultrathin 2D Nonlayered Tellurium Nanosheets: Facile Liquid‐Phase Exfoliation, Characterization, and Photoresponse with High Performance and Enhanced StabilityAdvanced Functional Materials, 2018